A Randomized, Double-blind, Placebo-controlled, Parallel-group, Comparative, Phase III Study to Evaluate the Efficacy and Safety of Nuvastatic® 300mg Capsule in Reducing Cancer-Tumor in Patients With Metastatic Colorectal Cancer Receiving Standard Chemotherapy.
Clinical trial NCT07669454 · RECRUITING
Trial details
- NCT number
- NCT07669454
- Sponsor
- Natureceuticals Sdn Bhd
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-01
- Primary completion
- 2026-10-31
- Enrollment
- 250
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.